What is the main business of Mille Medica?

The main business activity of Mille Medica focuses on specialist medical practice activities.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on January 9, 2004.

Where is the headquarters located?

The headquarters is located at: Lanciego 13, 02-792 Warszawa.

What is the share capital?

The share capital of the company is PLN 600,000 (approx. $162,075).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.

What was the revenue?

The company reported a revenue of $396,444 in 2025, which is an increase of 4.8% compared to 2024.

Is the company profitable?

Yes, the company recorded a net profit of $10,770 in 2025, meaning the company increased its profit by 44.6%.

Which cost dominates operating expenses?

The largest operating cost category falls under external services. This category amounted to $236,546 in 2025, representing 62% of all operating expenses.

Mille Medicasp. z o.o.

Specialist medical practice activities

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2004-01-09

Share capital

600,000.00 PLN

Activity description

Mille Medica is a family medical clinic founded in 2006, with otolaryngology, including paediatric care, as its core specialty. The clinic provides consultations and allergy treatment, care for snoring and sleep apnoea, and ENT and dermatological procedures under local anaesthesia.

Registered address

Lanciego 13/4 i 5, 02-792 Warszawa, Poland

Website

millemedica.pl

Opening hours

Monday–Friday: 9:00–20:00

Phone

Social media

Electronic delivery address

AE:PL-81133-51644-AGSEU-14

Financials

Revenue history (in k)

From the notes

Current income tax (CIT due)	$1,065
Profit allocation	No decision
Loans and borrowings	$13,812
Capital expenditure	$16,013

Filing timeliness

Financial statements were filed on time, on average 150 days early.

202511/03/2026
202407/03/2025
202301/03/2024
202210/03/2023
202123/02/2022
202019/02/2021

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue

This companyUSD 396.44kMedianUSD 443.52kAverageUSD 1.75m

Net profit

This companyUSD 10.77kMedianUSD 14.31kAverageUSD 129.53k

Operating costs

This companyUSD 383.66kMedianUSD 397.10kAverageUSD 1.56m

Assets

This companyUSD 223.90kMedianUSD 173.92kAverageUSD 1.02m

News

2021-10-21

Invitation to participate in clinical trial at Mille Medica

2021-02-01

We supported the WOŚP fundraiser at Mille Medica

2020-04-21

Mille Medica clinic resumes ENT consultations

2020-02-10

Mille Medica – patient-friendly facility awarded certificate

Industry

Offer

Otolaryngology consultations
Paediatric otolaryngology consultations
Phoniatric consultations
Dermatology consultations
Dietetic consultations
Speech therapy consultations
Snoring and sleep apnoea treatment

Website technology

Online shop

WooCommerce

Website

WordPress
Elementor

Analytics and marketing

Google Analytics
Google Tag Manager
Hotjar

Trademarks

Mille Medica currently holds no active trademarks with the Polish Patent Office. 2 marks have expired or were not registered. The first mark was filed in 2012.

Mark	Number	Classes	Status	Protected until
INSTYTUT MEDYCYNY SNU(word)	Z.439793	41, 44	Expired	–
INSTYTUT MEDYCYNY SNU(word)	Z.395457	41, 44	Not registered	–

Mark	Protected until
INSTYTUT MEDYCYNY SNU(word)	–
INSTYTUT MEDYCYNY SNU(word)	–

Authorized Representatives

Andrzej Antoni Kukwa – President of the Management Board

Wojciech Sebastian Kukwa – Zastępca Prezesa

Manner of representation

Members of the management board jointly.

Ownership

Owner	Shares	Share value	Stake
Andrzej Antoni Kukwaage 85	600	$81,037.28	50%
Wojciech Sebastian Kukwaage 50	600	$81,037.28	50%

Andrzej Antoni Kukwa and Wojciech Sebastian Kukwa hold a combined 100% – the ownership structure indicates family control.

Beneficial owners

Person	Rights

Bank accounts

Registered as a VAT taxpayer on 2006-03-16.

Bank Pekao SA
90 1240 6218 1111 0010 3536 5368

Debt

No entries in the National Debtors Register (KRZ).

Real estate

Type	Amount
Buildings and premises	PLN 90,728PLN 90,728

Public aid

4 public aid cases recorded, with a total value of $16,011.

Grant date	Purpose	Gross amount	Granting body
Jun 20, 2020	Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts	$1,566$1,566	Prezes Zakładu Ubezpieczeń Społecznych
May 30, 2020	Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts	$1,071$1,071	Prezes Zakładu Ubezpieczeń Społecznych
May 30, 2020	Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts	$1,066$1,066	Prezes Zakładu Ubezpieczeń Społecznych

Regulatory authorisations

Authority	Type	Status
BDO	BDO register entry	Active

Competitors

Name	Revenue	Website
MD Clinic Pragasp. z o.o.	$1,054,408.29	mdclinic.pl
Astimedsp. z o.o.	$516,089.75	astimed.pl
Klinika 37sp. z o.o. + limited partnership	$490,176.54	klinika37.pl
Arkmedicsp. z o.o.	$462,335.60	arkmedic.pl
Nobilismedsp. z o.o.	$417,187.01	nobilismed.pl
Medcare Groupsp. z o.o.	$356,511.18	medcarejozefow.pl
Oxford Medsp. z o.o.	$343,436.19	oxfordmed.pl
Mbmedsp. z o.o.	$287,935.65	mbmed.pl
Prof-Medicosp. z o.o.	$280,896.72	prof-medico.pl
Almimedsp. z o.o.	$273,006.72	almimed.com

Change history

Date	Event
2015-03-20	Switch to PKD 2007 (2 PKD 2004 codes → 7 PKD 2007 codes)
2011-12-22	Share capital increase (50,000.00 PLN → 600,000.00 PLN)
2004-01-09	Entered in the register

FAQ

Last updated: 2026-04-09